Coaching Compounded Semaglutide + B12
$249.00/ month
Quantity
Includes telehealth consult, customized dosing protocol, and dedicated transformation coaching
This program provides access to a licensed medical provider via telehealth through our partner network (e.g., Qualiphy) and includes professional coaching to help you achieve sustainable fat loss and metabolic health. All medications are only prescribed when medically appropriate following a licensed provider review. If you are not approved, you will receive a full refund. DNA Fit Labs does not prescribe or sell medications directly. Prescriptions are fulfilled solely by U.S.-licensed compounding pharmacies.
Semaglutide is a GLP-1 receptor agonist, clinically proven to help patients lose 15–20% of their body weight by suppressing appetite, improving insulin function, and slowing digestion. When paired with methylcobalamin (vitamin B12), this therapy not only maximizes weight loss, but also helps maintain energy, mood, and metabolic balance throughout the process.
GLP-1 (Glucagon-Like Peptide-1):
Delays gastric emptying → keeps you fuller for longer
Reduces appetite & food cravings
Improves insulin sensitivity and glycemic control
Lowers risk factors for cardiometabolic disease
Supports energy production and reduces fatigue
Enhances mood, focus, and mental clarity
Promotes nerve health & red blood cell formation
Helps offset potential fatigue or nausea from GLP-1 therapy
Clinically proven fat loss (average 15–20% body weight reduction)
Powerful appetite suppression & portion control
Improved insulin sensitivity & metabolic balance
Increased energy and mood support from B12
Lowered risk of weight regain with integrated coaching
Effective support for prediabetes, PCOS, or insulin resistance
Form: Sterile compounded injectable solution
Base Medication: Semaglutide (GLP-1 receptor agonist)
Additive: Methylcobalamin (Vitamin B12)
Administration: Subcutaneous injection (weekly)
Storage: Refrigerate after opening
Dosing Protocol: Customized by licensed provider
Purity: ≥ 99% pharmaceutical-grade
Fulfillment: U.S.-licensed compounding pharmacies only
HIPAA-compliant telehealth with licensed providers
Customized medical evaluation & dosing protocol
No “research only” or grey-market products
Ongoing coaching, accountability, and lifestyle support
Proven protocols tailored to your goals
Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity. NEJM (2021)
Davies M, et al. Semaglutide as a treatment for Type 2 Diabetes. Lancet Diabetes Endocrinol (2017)
He L, et al. B12 deficiency and fatigue in obese patients under caloric restriction. Nutrition Research (2020)
⚠️ Important Note: Semaglutide + B12 injections are prescription-only and should only be used under the supervision of a licensed healthcare provider. Compounded medications are not FDA-approved and are intended for use only after a thorough medical evaluation.
Peptide Therapy Disclaimer
Although our partner pharmacies use only FDA-approved ingredients that are pharmaceutical-grade and highly regulated, compounded prescriptions are not FDA approved
This website and any content provided herein are for informational and educational purposes only.
We are not a medical provider. All medications, including peptide therapies, are prescribed and managed exclusively by licensed medical professionals through a third-party medical group, Qualiphy PC. Any medical evaluations, diagnoses, prescriptions, or treatment decisions are made solely by those providers following a telehealth consultation and in accordance with applicable state and federal laws.
Our role is to support clients with non-medical coaching services such as fitness guidance, nutrition planning, and lifestyle accountability. We do not diagnose, treat, or prescribe medications. We are not responsible for the outcomes or effects of any medical treatment prescribed by third-party providers.
Always consult with a licensed healthcare provider before starting or stopping any medical treatment. If you have questions or concerns related to your medication, please contact the prescribing provider.